Volume 15, Issue 1 supplement

Search all The European Journal of Health Economics articles

May 2014

Biological and biosimilar therapies in inflammatory conditions: challenges for the Central and Eastern European Countries

Issue Editor:

László Gulácsi

17 articles in this issue

Biological and biosimilar therapies in inflammatory conditions: challenges for the Central and Eastern European countries
László Gulácsi
Editorial 16 May 2014 Pages: 1 - 4
Statistical and regulatory considerations in assessments of interchangeability of biological drug products
Lászlo Tóthfalusi
László Endrényi
Shein-Chung Chow
Original Paper Open access 16 May 2014 Pages: 5 - 11
Health technology assessment in Poland, the Czech Republic, Hungary, Romania and Bulgaria
László Gulácsi
Alexandru M. Rotar
Niek S. Klazinga
Original Paper 16 May 2014 Pages: 13 - 25
Transferability of results of cost utility analyses for biologicals in inflammatory conditions for Central and Eastern European countries
László Gulácsi
Fanni Rencz
Petra Baji
Original Paper 16 May 2014 Pages: 27 - 34
Biological therapy in inflammatory rheumatic diseases: issues in Central and Eastern European countries
Márta Péntek
Gyula Poór
László Gulácsi
Original Paper 16 May 2014 Pages: 35 - 43
Comparative efficacy and safety of biosimilar infliximab and other biological treatments in ankylosing spondylitis: systematic literature review and meta-analysis
Petra Baji
Márta Péntek
Valentin Brodszky
Original Paper Open access 16 May 2014 Pages: 45 - 52
Efficacy and safety of infliximab-biosimilar compared to other biological drugs in rheumatoid arthritis: a mixed treatment comparison
Petra Baji
Márta Péntek
Valentin Brodszky
Original Paper 16 May 2014 Pages: 53 - 64
Budget impact analysis of biosimilar infliximab (CT-P13) for the treatment of rheumatoid arthritis in six Central and Eastern European countries
Valentin Brodszky
Petra Baji
Márta Péntek
Original Paper 16 May 2014 Pages: 65 - 71
Acceptability of less than perfect health states in rheumatoid arthritis: the patients’ perspective
Márta Péntek
Bernadette Rojkovich
László Gulácsi
Original Paper 16 May 2014 Pages: 73 - 82
Subjective health expectations at biological therapy initiation: a survey of rheumatoid arthritis patients and rheumatologists
Márta Péntek
László Gulácsi
Werner B. F. Brouwer
Original Paper 16 May 2014 Pages: 83 - 92
Real-life experience with switching TNF-α inhibitors in ankylosing spondylitis
Katalin Gulyas
Nora Bodnar
Sandor Szanto
Original Paper 16 May 2014 Pages: 93 - 100
Cost-of-illness in patients with moderate to severe psoriasis: a cross-sectional survey in Hungarian dermatological centres
Orsolya Balogh
Valentin Brodszky
Péter Holló
Original Paper 16 May 2014 Pages: 101 - 109
Exploring the relationship between EQ-5D, DLQI and PASI, and mapping EQ-5D utilities: a cross-sectional study in psoriasis from Hungary
Emese Herédi
Fanni Rencz
Valentin Brodszky
Original Paper 16 May 2014 Pages: 111 - 119
Work disability and productivity loss in patients with inflammatory bowel diseases in Hungary in the era of biologics
Mandel D. Michael
Anita Bálint
Péter L. Lakatos
Original Paper 16 May 2014 Pages: 121 - 128
Erratum to: Work disability and productivity loss in patients with inflammatory bowel diseases in Hungary in the era of biologics
Michael D. Mandel
Anita Bálint
Péter L. Lakatos
Erratum 29 May 2014 Pages: 129 - 129
Economic burden of long-term care of rheumatoid arthritis patients in Hungary
Zoltán Horváth
Andor Sebestyén
Imre Boncz
Original Paper 16 May 2014 Pages: 131 - 135
Changes in the health status of the population of Central and Eastern European countries between 1990 and 2010
Imre Boncz
Réka Vajda
Andor Sebestyén
Original Paper 16 May 2014 Pages: 137 - 141

Volume 15, Issue 1 supplement

Search

Navigation